Toshitaka Shin

Which Patients with Negative Magnetic Resonance Imaging Can Safely Avoid Biopsy for Prostate Cancer?

Masakatsu Oishi, Toshitaka Shin, Chisato Ohe et al. · The Journal of Urology · 2018 · 88 citations

Autocrine expression of neurotrophins and their receptors in prostate cancer

Fuminori Satoh, Hiromitsu Mimata, T Nomura et al. · International Journal of Urology · 2001 · 58 citations

Autocrine Expression, Urology, Perineural Invasion +12

Dual targeting of heat shock proteins 90 and 70 promotes cell death and enhances the anticancer effect of chemotherapeutic agents in bladder cancer

Liang Ma, Fuminori Sato, Ryuta Sato et al. · Oncology Reports · 2014 · 47 citations · Full text

Chemoprevention Strategy, Cell Death, Cancer Biology +20

Efficacy and safety of abiraterone acetate plus prednisone in Japanese patients with newly diagnosed, metastatic hormone-naive prostate cancer: final subgroup analysis of LATITUDE, a randomized, double-blind, placebo-controlled, phase 3 study

Hiroyoshi Suzuki, Toshitaka Shin, Satoshi Fukasawa et al. · Japanese Journal of Clinical Oncology · 2020 · 44 citations · Full text

Diagnostic accuracy of a five‐point Likert scoring system for magnetic resonance imaging (MRI) evaluated according to results of MRI/ultrasonography image‐fusion targeted biopsy of the prostate

Toshitaka Shin, Thomas B. Smyth, Osamu Ukimura et al. · British Journal of Urology · 2017 · 43 citations · Full text